GSK and Pfizer launch HIV company ViiV
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and Pfizer have launched their HIV joint venture ViiV Healthcare and have appointed GSK's former senior vice-president and head of personalised medicine strategy Dr Dominique Limet CEO of the new company.